<DOC>
	<DOC>NCT01148771</DOC>
	<brief_summary>The purpose of this study is to characterize and compare the concentration-time profiles and multiple dose pharmacokinetics of a 5 minute intravenous (IV) bolus of ertapenem 1 gram daily versus the standard 30 minute infusion in healthy volunteers. Safety and tolerability and pharmacodynamic target attainment using Monte Carlo simulation will also be assessed and compared.</brief_summary>
	<brief_title>Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion</brief_title>
	<detailed_description />
	<mesh_term>Ertapenem</mesh_term>
	<criteria>Healthy adults (18 years of age or older) Ertapenem or other betalactam allergy Pregnant or breast feeding females Body Mass Index (BMI) greater than or equal to 30 Abnormal lab values at baseline Hypertension Significant medical abnormality Regular alcohol consumption Significant nicotine use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Safety</keyword>
</DOC>